01 The visual prosthesis market is shifting toward wireless retinal implants, wearable imaging systems, and brain-based visual interfaces designed to provide useful artificial vision. Research is moving beyond simple light perception toward recognizing shapes, letters, and everyday objects. Retinal prostheses remain important for people whose inner retinal pathways still function, while cortical systems could potentially help patients with severe retinal or optic-nerve damage. Digital features such as image processing, zoom, and contrast enhancement are also becoming important parts of these systems. This shift is increasing competition around smaller implants, wireless operation, improved visual resolution, long-term reliability, and measurable improvements in patients’ daily activities. In October 2025, a Stanford Medicine-led PRIMA retinal prosthesis trial reported that 27 of 32 participants with advanced macular degeneration regained reading ability one year after implantation.
January 2026 Pixium Vision continued advancing its retinal prosthesis and bionic vision technologies through ongoing clinical development activities aimed at improving vision restoration for patients with degenerative retinal diseases.
November 2025 Bionic Vision Technologies advanced the development of its next-generation visual prosthesis platform, focusing on improving artificial vision performance and expanding clinical research for retinal implant technologies.
September 2025 Cortigent, Inc. expanded development of its neurostimulation-based visual prosthesis technologies, supporting continued innovation in implantable systems for vision restoration.
July 2025 Second Sight Medical Products continued supporting research and development activities related to retinal prosthesis technologies and implantable visual restoration systems through collaborations in neurostimulation and ophthalmic innovation.